AstraZeneca to buy pharmaceutical firm Alexion for $39 billion
NEW DELHI: Cambridge, England-based AstraZeneca PLC, which is involved in one of the efforts to develop a COVID-19 vaccine, said...
AstraZeneca
Not without India: World’s pharmacy gears up for Covid-19 vaccine race
By Abhirup Roy, Euan Rocha, Krishna N. DasPUNE/NEW DELHI: India, the worlds biggest vaccine maker, is getting set for the...
Analysis: Questions over AstraZeneca’s COVID-19 vaccine data risk delaying approval
LONDON: Days after grabbing headlines with its COVID-19 vaccine for the world, AstraZeneca is facing tricky questions about its success...
Covid-19 vaccine review: Narendra Modi to visit Bharat Biotech, Serum Institute and Zydus Biotech Park on Saturday
NEW DELHI: The Prime Minister Narendra Modi is scheduled to visit vaccine maker Bharat Biotech's facility here on Saturday, the Telangana...
AstraZeneca manufacturing error clouds COVID-19 vaccine study results
By DANICA KIRKALONDON: AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results...
When and which COVID-19 vaccines are likely to be available in Asia
NEW DELHI: Pfizer Inc with partner BioNTech SE, Moderna Inc and AstraZeneca Plc have released trial data this month showing...
Q&A: Where are we in the COVID-19 vaccine race?
NEW DELHI: Drug makers and research centres around the world are working on COVID-19 vaccines, with large global trials of...
